MATERIALS AND METHODS
Samples of amniotic fluid were obtained from 34 pregnant women, 23 normal and 11 toxemic gravids at the time of labor.
None, of the normal pregnant women showed any clinical abnormality to term. All of the toxemic patie-its, who had hypertension, protein uria and edema, were diagnosed by the criteria of the American Committee on Maternal Welfare.
Thirty samples were collected after spontaneous rupture of the fetal membranes. In the remaining 4 cases of severe toxemic pregnancy the samples were taken at Cesarean section.
The fluid was centrifuged immediately after sampling at room temperature and the supernatant was used for the experiment. Five ml of amniotic fluid were added to 10 ml of human plasma adjusted to pH 5.5. Another 10 ml aliquot of the same plasma as used above was treated as a blank, in which 5 ml of physiological saline were added instead of amniotic fluid. Then the mixture was and K. Yoshinaga angiotensinase-free.
Doses of amniotic fluid
The rate of angiotensin formation by incubating 10 nil of human plasma and various amounts of amniotic fluid from 0.5 to 20 nil was examined. The plasma used here was obtained from several volunteers, and the mixture of plasma and anmiotic fluid was divided into 10ml aliquots. The results are illustrated in Fig. 1 , in which it can be seen that the rate of angiotensin production is dependent on and proportionate to the amount of added amniotic fluid. From these results, the finally decided condition for estimation of amniotic renin activity was to incu bate one volume of amniotic fluid with two volumes of human plasma.
Assay of renin activity in amniotic fluid Fig. 2 shows the results on renin activity in amniotic fluid from normal and toxemic pregnant women. In normal pregnancy the activity ranged from 60 to 300
Renin activity in amniotic fluid (ng equiv. to angiotensin II/10ml of amniotic fluid) 
DISCUSSION
It is evident from the present findings that amniotic fluid contains a large amount of pressor enzyme, the properties of which are similar to those of renin. This enzyme in amniotic fluid reacted with human plasma to produce a vaso constrictive substance comparable to angiotensin. However, there was no substrate of the enzyme in amniotic fluid. Gomel and Hardwick14 failed to detect a pressor substance in amniotic fluid in toxemic pregnancy. On the contrary, the present experiments demonstrate that amniotic renin activity was highly increased in toxemic pregnancy in comparison with that in normal preg nancy. This discrepancy could be possibly attributed to that the above authors did not take the substrate into consideration in their experiments.
The origin of this pressor enzyme in amniotic fluid has not been investigated in the present study. 
